The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
MabThera
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2010-01845-3-4
Submission Type
New dosage regimen